These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
208 related items for PubMed ID: 3519522
1. Immunization against experimental Pseudomonas aeruginosa and Serratia marcescens keratitis. Vaccination with lipopolysaccharide endotoxins and proteases. Kreger AS, Lyerly DM, Hazlett LD, Berk RS. Invest Ophthalmol Vis Sci; 1986 Jun; 27(6):932-9. PubMed ID: 3519522 [Abstract] [Full Text] [Related]
5. Role of bacterial proteases in pseudomonal and serratial keratitis. Matsumoto K. Biol Chem; 2004 Nov; 385(11):1007-16. PubMed ID: 15576320 [Abstract] [Full Text] [Related]
9. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection. Zaidi TS, Priebe GP, Pier GB. Infect Immun; 2006 Feb; 74(2):975-83. PubMed ID: 16428743 [Abstract] [Full Text] [Related]
10. Monoclonal antibodies provide protection against ocular Pseudomonas aeruginosa infection. Moon MM, Hazlett LD, Hancock RE, Berk RS, Barrett R. Invest Ophthalmol Vis Sci; 1988 Aug; 29(8):1277-84. PubMed ID: 2843483 [Abstract] [Full Text] [Related]
11. Pseudomonas deficient in protease IV has significantly reduced corneal virulence. Engel LS, Hobden JA, Moreau JM, Callegan MC, Hill JM, O'Callaghan RJ. Invest Ophthalmol Vis Sci; 1997 Jul; 38(8):1535-42. PubMed ID: 9224281 [Abstract] [Full Text] [Related]
12. Therapeutic effect of immunization with OEP, protease toxoid and elastase toxoid on corneal ulcers in mice due to Pseudomonas aeruginosa infection. Hirao Y, Homma JY. Jpn J Exp Med; 1978 Feb; 48(1):41-51. PubMed ID: 97424 [Abstract] [Full Text] [Related]
13. Pathogenesis of the mouse keratitis produced with Pseudomonas aeruginosa. Kawaharajo K, Homma JY. Jpn J Exp Med; 1975 Dec; 45(6):515-24. PubMed ID: 822189 [Abstract] [Full Text] [Related]
14. [Effects of an antiserum prepared against purified protease of pseudomonas aeruginosa (authors transl)]. Sezen IY, Scharmann W, Blobel H. Zentralbl Bakteriol Orig A; 1975 Dec; 231(1-3):126-32. PubMed ID: 808047 [Abstract] [Full Text] [Related]
15. Characterization of rabbit corneal damage produced by Serratia keratitis and by a serratia protease. Lyerly D, Gray L, Kreger A. Infect Immun; 1981 Sep; 33(3):927-32. PubMed ID: 7026449 [Abstract] [Full Text] [Related]
16. Functional role of antibody against "core" glycolipid of Enterobacteriaceae. Young LS, Stevens P, Ingram J. J Clin Invest; 1975 Oct; 56(4):850-61. PubMed ID: 1099119 [Abstract] [Full Text] [Related]
17. Protective activity of immune sera against extracellular slime from Pseudomonas aeruginosa on experimental infection in mice. Sokalska M, Maresz-Babczyszyn J. Arch Immunol Ther Exp (Warsz); 1981 Oct; 29(5):643-52. PubMed ID: 6812542 [Abstract] [Full Text] [Related]
18. Pseudomonas aeruginosa protease IV produces corneal damage and contributes to bacterial virulence. Engel LS, Hill JM, Moreau JM, Green LC, Hobden JA, O'Callaghan RJ. Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):662-5. PubMed ID: 9501882 [Abstract] [Full Text] [Related]
19. Corneal virulence of Pseudomonas aeruginosa elastase B and alkaline protease produced by Pseudomonas putida. Thibodeaux BA, Caballero AR, Marquart ME, Tommassen J, O'Callaghan RJ. Curr Eye Res; 2007 Apr; 32(4):373-86. PubMed ID: 17453960 [Abstract] [Full Text] [Related]
20. Relevance of host-derived and bacterial factors in Pseudomonas aeruginosa corneal infections. Steuhl KP, Döring G, Henni A, Thiel HJ, Botzenhart K. Invest Ophthalmol Vis Sci; 1987 Sep; 28(9):1559-68. PubMed ID: 3305411 [Abstract] [Full Text] [Related] Page: [Next] [New Search]